Genentech, Inc. - Company & Market Research Reports

Home /
Companies /
Genentech, Inc.

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 121
Immune Disorders Drugs 62
Drug Discovery 57
Biopharmaceuticals 39
Central Nervous System Drugs 36
Genomics 33
Optical Disorders Drugs 32
Pharmaceuticals 30
Optical 28
Respiratory Drugs 28
Clinical Trials 25
Biotechnology 24
Endocrine and Metabolic Disorders Drugs 23
Cardiovascular Drugs 21
Women's Health 21
Lung Cancer Drugs 21
Breast Cancer Drugs 20
Hematological Drugs 19
Musculoskeletal Disorders Drugs 18
Infectious Diseases Drugs 17
Biosimilars and Biosuperiors 17
Infusions and Injectables 16
Skin Cancer Drugs 15
Lymphoma Drugs 14
Colon Cancer Drugs 14
Kidney Cancer Drugs 14
Oncology 14
Pulmonary Medicine 13
Enzymes 13
Pharmaceutical Manufacturing 13
Allergy and Immunology 12
Leukemia Drugs 11
Liver and Kidney Disorders Drugs 11
Ovarian Cancer Drugs 10
Cervical Cancer Drugs 10
Diagnostics 10
Gastrointestinal Drugs 10
Brain Cancer Drugs 9
Needles and Syringes 9
Dermatological Drugs 9
Prostate Cancer Drugs 8
Bladder Cancer Drugs 8
Hospital Information Systems 8
Hematology 8
Pancreatic Cancer Drugs 8
Allergy Drugs 8
Sexual and Reproductive Health Drugs 7
Therapeutic Area 6
Liver Cancer Drugs 6
Drug Delivery 6
Vaccines 6
Immunosuppressive Drugs 6
Neurology 5
In Vitro Diagnostics 5
HIV/AIDS Drugs 5
Alzheimer's Disease Drugs 5
Urological Disorders Drugs 5
Pharmaceutical Intermediates 4
Healthcare Services 4
Proteomics 4
Dermatology 4
Cardiology 4
Drugs by Therapeutic Area 3
Diabetes Drugs 3
Transdermal and Transmucosal Drug Delivery 3
Company Reports 2
Animal Pharmaceuticals 2
Patient Monitoring Equipment 2
Urology and Nephrology 2
Infectious Disease Testing 2
Laboratory Testing 2
Biomaterials 2
Medical Devices 2
Biomarkers 2
Cancer Vaccines 2
Thyroid Cancer Drugs 2
Uterine Cancer Drugs 2
Nanomedicine 2
Laboratory Equipment 2
Pediatrics 2
Gastroenterology 2
Asthma Drugs 2
Psoriasis Drugs 2
Generic Drugs 1
Pharmacoeconomics 1
Medical Imaging 1
Orthopedic Devices 1
Drug Abuse Screening 1
Analgesics 1
Cough and Cold Drugs 1
Managed Care 1
Radiography 1
Stem Cells 1
Surgical Procedures 1
Over the Counter (OTC) Drugs 1
Contrast Media 1
Nuclear Medicine and Radiopharmacology 1
Vitamins and Dietary Supplements 1
Antibiotics 1
Endocrinology 1
Maternal and Neonatal Care 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



272 reviews

752 Results (Page 32 of 38)
- Relevance
  Sort by

Neurofibroma - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1827EUR$2,000USD£1,558GBP

KRAS Inhibitors - Market Size, Target Population, Competitive Landscape & Market Forecast - 2034

 Report
April 2025
200 Pages
Global

From

€7262EUR$7,950USD£6,193GBP

CD (Cluster Of Differentiation) Inhibitor - Pipeline Insight, 2025

 Clinical Trials
April 2025
120 Pages
Global

From

€1827EUR$2,000USD£1,558GBP

TIGIT Inhibitors - Pipeline Insight, 2025

 Drug Pipelines
April 2025
60 Pages
Global

From

€1827EUR$2,000USD£1,558GBP

Proto Oncogene Protein C-akt Inhibitors - Pipeline Insight, 2025

 Drug Pipelines
April 2025
60 Pages
Global

From

€1827EUR$2,000USD£1,558GBP

NEED HELP FINDING THE RIGHT PRODUCT? Hoseok will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Selective Estrogen Receptor Degraders - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1370EUR$1,500USD£1,168GBP

Indoleamine 2,3 Dioxygenase 1 Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
October 2024
90 Pages
Global

From

€3500EUR$4,104USD£3,089GBP

Enzyme Inhibitor Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
89 Pages
Global

From

€3500EUR$4,104USD£3,089GBP

Mitogen Activated Protein Kinase Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
August 2024
95 Pages
Global

From

€3500EUR$4,104USD£3,089GBP

Precision Cancer Therapeutics, 2022

 Report
November 2022
154 Pages
Global

From

€4568EUR$5,000USD£3,895GBP

Anticancer Drug Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F

 Report
May 2024
184 Pages
Global

From

€4111EUR$4,500USD£3,505GBP

Intravitreal Injectables Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

 Report
August 2022
118 Pages
Global

From

€4111EUR$4,500USD£3,505GBP

Antibody Fragments Market Size, Share & Trends Analysis Report by Specificity (Monoclonal Antibodies, Polyclonal Antibodies), by Type, by Therapy, by Application, by Region, and Segment Forecasts, 2022-2030

 Report
August 2022
150 Pages
Global

From

€5435EUR$5,950USD£4,635GBP

Cancer Therapy - Market Insights, Competitive Landscape, and Market Forecast - 2030

 Report
July 2024
100 Pages
Global

From

€3426EUR$3,750USD£2,921GBP

Urothelial Cancer Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)

 Report
April 2023
112 Pages
Global

From

€4339EUR$4,750USD£3,700GBP

Pharmaceutical Spray Drying Market (2nd Edition), 2018-2028

 Report
April 2018
200 Pages
Global

From

€3196EUR$3,499USD£2,726GBP

Pancreatic Cancer - Pipeline Review, H2 2020

 Drug Pipelines
September 2020
4317 Pages
Global

From

€2284EUR$2,500USD£1,947GBP

Oncology Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030

 Drug Pipelines
July 2024
100 Pages
Global

From

€3426EUR$3,750USD£2,921GBP

$Checkpoint Inhibitor Refractory Cancer - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image$

Checkpoint Inhibitor Refractory Cancer - Market Insight, Epidemiology and Market Forecast - 2034

 Report
June 2024
200 Pages
Global

From

€7262EUR$7,950USD£6,193GBP

HER2+ Gastric Cancer - Market Insight, Epidemiology and Market Forecast - 2034

 Report
June 2024
200 Pages
Global

From

€7262EUR$7,950USD£6,193GBP

752 Results (Page 32 of 38)
- 1
- 30
- 31
- 32
- 33
- 34

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.